Protective effects of hominis placenta hydrolysates on radiation enteropathy in mice

Nat Prod Res. 2011 Dec;25(20):1988-92. doi: 10.1080/14786419.2010.513035. Epub 2011 Jun 27.

Abstract

The aim of this study was to investigate whether the hominis placenta hydrolysates (HPhs) have a protective effect against radiation-induced enteropathies. HPh (1-10 mg kg⁻¹, i.p.) was treated to C57BL/6 mice, once daily for 5 days. Mice were irradiated (10 Gy) 1 h after the last injection. Cell damage was investigated at 24 and 72 h by haematoxylin-eosin staining, and the apoptotic index was determined at 24 h by deoxynucleotidyl transferase-mediated dUTP nick end labelling staining. The results showed that the HPh alleviated radiation-induced damage of crypts and suppressed apoptosis dose dependently. In conclusion, hominis placenta might be a beneficial agent against radiation-induced intestinal complications.

Publication types

  • Comparative Study

MeSH terms

  • Animals
  • Apoptosis / drug effects
  • Enteritis / etiology
  • Enteritis / prevention & control*
  • Female
  • Histological Techniques
  • In Situ Nick-End Labeling
  • Intestine, Small / cytology
  • Intestine, Small / pathology
  • Mice
  • Pelvic Neoplasms / radiotherapy*
  • Placenta / chemistry*
  • Pregnancy
  • Protein Hydrolysates / analysis
  • Protein Hydrolysates / therapeutic use*
  • Radiation Injuries, Experimental / pathology
  • Radiation Injuries, Experimental / prevention & control*
  • Radiation-Protective Agents / therapeutic use*
  • Radiotherapy / adverse effects*

Substances

  • Protein Hydrolysates
  • Radiation-Protective Agents